Latest Cancer: Kidney news
Triplet Therapy Ups Progression-Free Survival in Advanced Kidney Cancer
posted September 27th
by modernClinician Editorial Team
by modernClinician Editorial Team
Adjuvant Nivolumab + Ipilimumab Lacks Efficacy for Localized RCC
posted September 14th
by modernClinician Editorial Team
by modernClinician Editorial Team
Belzutifan Active in Renal Cell Carcinoma Associated With VHL Disease
posted December 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
Treatments Compared for Advanced Renal Cell Carcinoma
posted December 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis Related Articles
Pembrolizumab-Belzutifan Tied to Improved Disease-Free Survival in Renal Cell Carcinoma 
Comparable Progression Risk Seen With Ablation Versus Surgery for T1a Renal Cell Carcinoma 
Incidence Rates Increased From 2003 to 2017 for Six Cancer Types in 42 Countries 
Global Burden of Renal Cancer Expected to Double by 2050 Monthly Specialist Briefings
Stay Connected
